VEGF Trap-Eye Improves Vision in Diabetes Patients

eye

Vascular Endothelial Growth Factor (VEGF) Trap-Eye provided a significant benefit to patients with diabetic macular edema in a phase II trial – and updated data now shows the initial improvements were sustained or increased a year later.

Read more

Posted in Medical Research